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Australian abalone production has been affected by outbreaks of abalone viral ganglioneuritis (AVG)
caused by a herpesvirus (AbHV). In this study, we undertook experimental transmission trials by
immersion to study the abalone immune response to infection with AbHV. Representative cellular and
humoural immune parameters of abalone, including total haemocyte count (THC), superoxide anion (SO)
and antiviral activity against herpes simplex virus type 1 (HSV-1), were examined in apparently healthy
(sub-clinical) and moribund abalone after challenge. In the early infection, sub-clinical stage (days 1e3),
THC was found to increase signiﬁcantly in infected abalone. TaqMan qPCR conﬁrmed 20.5% higher viral
load in moribund abalone compared to apparently healthy abalone, indicating that the abundance of
AbHV within abalone is linked to their clinical signs. At the clinical stage of infection, THC was signiﬁ-
cantly lower in moribund abalone, but increased in AbHV-exposed but apparently healthy abalone, in
comparison to non-infected controls. SO was reduced in all abalone that were PCR-positive for AbHV.
THC and SO level were found to be negatively correlated with the presence of AbHV in abalone, but no
effect of AbVH exposure was observed on the haemolymph antiviral activity. These results suggest that
abalone mount an initial cellular immune response to AbHV infection, but this response cannot be
sustained under high viral loads, leading to mortality.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Abalone viral ganglioneuritis (AVG) threatens the sustainability
of the abalone industries in south-eastern Australia [1]. AVG is
caused by infectionwith a herpesvirus [2], damaging neural tissues
and resulting in up to 90% mortality of farmed abalone within 7e14
days from the onset of clinical signs [1]. Phylogenetic analysis of the
DNA polymerase protein indicates that the abalone herpesvirus
(AbHV) belongs to the family Malacoherpesviridae and is distantly
related to other members of the Herpesviridae [2].
Abalone defense against viral infection relies on their innate
immune system, which consists of cellular and humoural compo-
nents [3]. Cellular immunity in molluscs, including abalone, is
centred on the activity of haemocytes, including the elimination of
infectious agents involving release of superoxide anion,. Benkendorff).
hip.
-NC-ND license.phagocytosis of microbial pathogens and the recognition and
elimination of infected cells [3,4]. Antimicrobial compounds acting
as humoural effectors of molluscan immunity can be constitutively
expressed and rapidly induced to provide an immediate response
to invading microorganisms [5,6].
Of the AVG outbreaks reported by Hooper et al. [1], a small
proportion of abalone survived (<10%). It is possible that survivors
possessed an enhanced immunity. In this study, we performed
in vivo infection trials (using abalone sourced from a farm with no
previous history of AVG), by direct immersion in water in which
AbHV was suspended [7,8], to examine abalone immune responses
during the ﬁrst week after exposure to AbHV. Total haemocyte
count, superoxide anion production in haemocytes and antiviral
activity in the haemolymph plasma were used as representative
cellular and humoural immune parameters of abalone to investi-
gate differences in immune responses between apparently healthy
and moribund abalone after challenge with AbHV. After immersion
of abalone in AbHV-infectious water, their immunity was assessed
at the early subclinical stage, and later, at the onset of disease.
Table 1
Effect of AbHV infection and time post-infection on A) total haemocyte count (THC,
cells  104 per ml), B) superoxide anion (SO, OD 620 nm), C) antiviral activity (%)
against HSV-1. Each immune parameter was measured from nine replicate abalone.
The asterisk (*) indicates signiﬁcant differences (p < 0.05) between virus-exposed
and negative control groups.
Time post-
challenge
Immune
parameter
PERMANOVA
Non-infected
control
AbHV-
exposed
p value
(pair-
wise test)
Day 1 THC (cells 
104 ml1)
281.33  28.1 289.33  21.07 0.84
Intracellular
SO (OD
620 nm)
0.15  0.03 0.15  0.03 0.94
Antiviral
activity (%)
48.24  5.8 54.93  2.98 0.31
Day 2 THC (cells 
104 ml1)
275.83  41.46 347.17  47.01 0.28
Intracellular SO
(OD 620 nm)
0.14  0.02 0.15  0.03 0.59
Antiviral
activity (%)
45.11  4.37 51.1  6.19 0.43
Day 3 THC (cells 
104 ml1)
276  22.63 381.5  39.08 0.04*
Intracellular
SO (OD
620 nm)
0.11  0.02 0.15  0.01 0.11
Antiviral
activity (%)
47.12  3.76 49.86  3.46 0.57
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Virus stock was obtained from abalone previously infected with
the Victorian isolate of AbHV (designated Vic-1) by homogenizing
neural tissue in Eagle’s Minimal Essential Medium containing 20%
foetal bovine serum, with a Dounce homogeniser, followed by
ﬁltration (0.22 mm) and the ﬁltrate stored in liquid nitrogen, until
use. AbHV-infectious water used for immersion challenge was
produced by injecting six abalone intramuscularly in the foot with
100 ml of this stock virus (w1105 viral gene copies (v.g.c.)/100 ml).
At day 4 post-inoculation, the water was harvested, titrated using
the AbHV TaqMan assay [7] and diluted 1:5 to generate the chal-
lenge AbHV-infectious water. The amount of AbHV in this water
was determined to be 15.6  106 v.g.c. ml1.
Haliotis laevigataHaliotis rubrahybrid abalone (n¼ 150, 7e8 cm
in shell length), obtained from Great Southern Waters Pty Ltd,
Victoria, were placed in experimental aquaria and acclimated at 15e
16 C for aweek in seawaterwith continuous aeration and daily 100%
water exchange. Abalone (n¼ 72) were challenged by immersion for
20h, in triplicate 40 L tanks in the infection room. Abalone (n¼ 72) as
negative controls were maintained in fresh seawater in triplicate
tanks in a separate non-infection room. Haemolymph and ganglia
were sampled from nine abalone from the infected and non-infected
(negative control) groups at days 1, 2 and 3.
Moribund abalone, demonstrating loose attachment to the
substrate, were collected on days 5, 6 and 7 for sampling their
haemolymph and ganglion. On the same days, haemolymph and
ganglionwere also sampled from apparently healthy abalone in the
infected room and negative control abalone from the non-infected
room (n ¼ 9 per day, 3 from each tank).
Ganglion sections, including ganglion tissues and surrounding
muscle from infected and uninfected abalone, were weighed.
Nucleic acid was extracted using QIAamp DNA mini kit (QIAGEN)
and stored at 80 C until required. ORF-49 qPCR [9] was carried
out on DNA extracts from abalone tissues according to established
protocols [7,9]. All abalone samples were tested by real-time Taq-
Man PCR (7500 Fast Real-time PCR system, Applied Biosystems) in
duplicate to obtain CT values. AbHV-negative samples were iden-
tiﬁed as having CT values >35.8 and AbHV-positive samples had CT
values <35. To quantify the number of AbHV gene copies
(v.g.c. ml1) in abalone samples from the CT value, a plasmid DNA
standard curve was prepared for plasmid Topo-ORF49 using serial
10-fold dilutions [7,9]. The qPCR assay for plasmid Topo-ORF49
produced a linear correlation between recombinant plasmid level
and CT value over 4 log10 dilutions (coefﬁcient R2 ¼ 0.99).
Fresh haemolymph (100 ml) was sampled from the anterior
sinus using a sterile syringe and needle (5 ml, 25G), then imme-
diately ﬁxed in 200 ml formalin (10%), in phosphate buffered saline
(PBS), in pre-cooled Eppendorff tubes and kept on ice. Total hae-
mocyte count for each haemolymph sample was obtained using an
improved Neubauer hemocytometer. Superoxide anion (SO)
production by haemocytes was quantiﬁed using reduction of
nitroblue tetrazolium (NBT) to formazan, as described in previous
studies [10e12] and measured at 620 nm on a microplate reader
(Multiskan Ascent, Thermo Electron Corporation). PBS was used as
negative control to measure the background breakdown of NBT.
Intracellular SO was expressed as haemolymph sample (150 ml)
absorbance e negative control absorbance.
The remaining haemolymph were centrifuged (1500 g, 5 min)
to obtain haemolymph plasma for antiviral assays. The plaque
reduction assay was used to measure antiviral activity of abalone
haemolymph against HSV-1, as previously described [13,14]. Hae-
molymph plasma (6%; v/v) was used throughout to compare anti-
viral activity (EC50 ¼ 6.23%, v/v, i.e. the concentration required to
inhibit HSV-1 plaque formation by 50%) [13].At the sub-clinical stage of infection (days 1e3), each abalone
immune parameter (THC, SO level, antiviral activity) was compared
between AbHV-exposed and non-infected abalone using two-
factor permutational analysis of variance in Primer V6 with PER-
MANOVA add-on [15]. Post-hoc planned comparisons were
undertaken between controls and treatments on each day using
pair-wise tests. At the clinical stage of infection (days 5e7), four
infected and non-infected abalone groups (1: negative control, 2:
AbHV-exposed, PCR-negative and apparently healthy, 3: infected
PCR-positive and apparently healthy, 4: PCR-positive and mori-
bund) were compared for each immune parameter using one-factor
univariate PERMANOVA. The correlation between v.g.c (log10) in
ganglion tissues and each immune parameter from AbHV-exposed,
PCR-positive abalone in the immersion trial was tested using
Pearson’s correlation coefﬁcient (PASW/SPSS statistics 18).3. Results and discussion
There was no mortality, or clinical signs in abalone, during the
ﬁrst three days after exposure to virus. All negative control abalone
were PCR-negative for AbHV (CT values >35.8). Challenged abalone
were all PCR-negative at days 1 and 2, and two out of the nine
abalone were PCR-positive at day 3 (CT values <35.8). This conﬁrms
that qPCR can detect sub-clinical AbHV infections [7]. Viral DNAwas
detected in abalone ganglion tissues but not in their haemolymph.
During the subclinical phase of infection, the level of SO and
antiviral activity against HSV-1 were not signiﬁcantly different
between AbHV-exposed and control groups (Table 1). However, the
mean THC in AbHV-exposed abalone increased over time and pair-
wise analysis detected signiﬁcant difference in THC between AbHV-
exposed and control abalone on day 3 (Table 1). An increase in
circulating haemocytes (THC) is a common stress response
observed in abalone in response to a wide range of abiotic (e.g.
handling, water temperature, salinity) and biotic stressors (e.g.
Vibrio sp. infections) [12,16,17]. Here we demonstrate that in the
early stages of exposure to virus, abalone will also mount an initial
immune response by increasing the number of circulating
AB
C
Fig. 1. Effect of AbHV infection status at the clinical stage on abalone immune
responses A) total haemocyte count (THC, cells  104 per ml), B) superoxide anion (SO,
OD 620 nm), C) antiviral activity (%) against HSV-1. Comparison was made between
non-infected negative control (n ¼ 27), AbHV exposed but apparently healthy and PCR-
negative (n ¼ 6), apparently healthy and PCR-positive for AbHV (n ¼ 23), and mori-
bund and PCR-positive (n ¼ 18) abalone. Different small letters indicate signiﬁcant
differences (p < 0.05) between groups.
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defense against pathogenic microbes, by mechanisms such as
phagocytosis and the release of cytotoxic compounds [18].
Abalone started showing clinical signs of ganglioneuritis (e.g.
loss of pedal adhesion to tank surface, loss of righting reﬂex) on day
5 after exposure to virus. In total, 18 moribund were sampled and
all were PCR-positive for AbHV (Supplementary Fig. 1). In addition,
29 healthy-looking but virus challenged abalone were sampled
from days 5e7, and of these 23 were PCR-positive, but with
a greater range of AbHV viral copies than moribund abalone
(Supplementary Fig. 1). Viral DNA was not detected in a small
proportion of apparently healthy abalone (n ¼ 6) that were also
exposed to AbHV by immersion. Longer-term experiments would
be required to conﬁrm whether these healthy-looking AbHV-
exposed abalone would ultimately succumb to the disease. Indeed,
100% cumulative mortality of abalone has been observed in
previous AbHV infection trials after 10 days [7].
At the clinical infection stage (days 5e7), THC was still elevated
in apparently healthy abalone that were PCR-negative (42.6%) and
PCR-positive (13.6%) for AbHV, but THC was signiﬁcantly lower in
moribund abalone (38.8%) in comparison to the negative controls
(Fig. 1A, p < 0.05). For PCR-positive abalone exposed to AbHV-
infectious water, THC was negatively correlated with number of
v.g.c. (log10) from abalone tissues (Pearson’s correlation coefﬁcient
r ¼ 0.33, p ¼ 0.03). This result is consistent with previous reports
of leucopenia in AbHV-infected abalone, where signiﬁcantly lower
THC was observed in farmed abalone with microscopic lesions, in
comparison to healthy abalone with no lesions indicative of AVG
[19]. The decrease in circulating haemocytes in moribund abalone
is most likely due to the sequestration of haemocytes to the
infected neural tissue [19]. A similar effect of reduced THC has been
reported for Paciﬁc white shrimp Litopenaeus vannamei infected
with white spot syndrome virus [20] and Taura syndrome virus
[21], thus emphasizing the central role of maintaining circulating
haemocytes for immunity against viruses in marine invertebrates.
A signiﬁcant change in SO level was observed when abalone
started showing clinical signs of disease (from day 5 post-
infection), with higher levels found in apparently healthy abalone
that were exposed to the virus and a signiﬁcant decrease in mori-
bund abalone, compared to negative controls (Fig. 1B, p < 0.05). No
signiﬁcant difference in SO was found between AbHV-exposed
healthy and moribund abalone, which were conﬁrmed to be PCR-
positive (p ¼ 0.1), or between healthy PCR-positive abalone and
negative control abalone (p ¼ 0.63). For all abalone that were
exposed to AbHV, the level of SO was positively correlated to THC
(r¼ 0.48, p< 0.01) and negatively correlated to the number of v.g.c.
(log10) in abalone tissues (r ¼ 0.53, p < 0.01). Since only the
volume of haemolymph, and not the number of haemocytes, was
standardized between samples in the SO assay, the relationship
between SO and viral load is mostly likely an indirect effect
contributed by the reduced THC in clinically infected abalone.
Consistent with our previous studies [11e14], a high level of
baseline antiviral activity against HSV-1 was observed in all treated
and control abalone. Antiviral activity against HSV-1 was not
signiﬁcantly higher in apparently healthy infected abalone
compared with moribund abalone (Fig. 1C, p > 0.05). Furthermore,
antiviral activity did not increase signiﬁcantly in abalone exposed
to AbHV, in comparison to the negative controls. Consequently,
there appears to be no ramping up of the constitutive levels of
antiviral activity present in the unchallenged animal on exposure to
AbHV. This suggests that there may not be an inducible component
to the synthesis of humoural antiviral (anti-HSV-1) compounds in
response to AbHV infection in abalone, which is in contrast to the
inducible synthesis of antibacterial factors in bivalves [22], some of
which also appear to have antiviral activity [23e25].In summary, changes to the abalone cellular immune response,
but not the humoural antiviral activity, can be observed in the early
stages of infection with AbHV. Abalone with low viral prevalence
have a high number of circulating haemocytes and associated
intracellular SO. Further research is required on the heritability of
the ability to mount a cellular immune response to pathogen
infection and speciﬁc antiviral factors in abalone that may help
confer resistance to AbHV.
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